1. Home
  2. IMXI vs BCYC Comparison

IMXI vs BCYC Comparison

Compare IMXI & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.79

Market Cap

460.6M

Sector

Technology

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.22

Market Cap

456.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
BCYC
Founded
1994
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.6M
456.4M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
IMXI
BCYC
Price
$15.79
$5.22
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$16.67
$17.56
AVG Volume (30 Days)
351.4K
318.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
9.82
42.91
EPS
0.79
N/A
Revenue
$319,601,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.95
N/A
P/E Ratio
$19.96
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$5.03
52 Week High
$15.81
$10.84

Technical Indicators

Market Signals
Indicator
IMXI
BCYC
Relative Strength Index (RSI) 66.76 37.13
Support Level $15.42 $5.03
Resistance Level N/A $5.90
Average True Range (ATR) 0.07 0.28
MACD 0.00 0.02
Stochastic Oscillator 90.32 22.54

Price Performance

Historical Comparison
IMXI
BCYC

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: